ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel
  • »
  • Health»
  • Diseases, Disorders & Conditions

Medical Significance of the Clinical manifestations Of Myeloproliferative Disorders: Myelofibrosis

Updated on February 3, 2014

Detecting Splenomegaly

Source

A General Overview

The disorders polycythemia vera (PV), chronic myeloid leukemia (CML), essential thrombocythemia and idiopathic myelofibrosis (IMF) are included under this broad group.

These disorders are grouped together since they arise from a common precursor stem cell which can proliferate and differentiate into one or other types. These disorders may show transformation into one or other types when followed up. Around 30% of cases of polycythemia vera develop chronic myelofibrosis, so also 70% of chronic myeloid leukemia, 10% of polycythemia vera may develop acute myeloid leukemia on follow up:

Primary Myelofibrosis

Also known as Agnogenic Myeloid Metaplasia, Myelosclerosis, Idiopathic myelofibrosis; it refers to the condition where there is diffused fibrosis of bone marrow, sometimes accompanied by osteosclerosis occurring as a primary abnormality. Compensatory hematopoiesis occurs in the spleen, bone marrow, lymph nodes and other organs. As the condition is fully established, reactive fibrosis occurs which replaces the hemopoietic tissues. Ossification may occur in these areas later.

Though, the disease is more common in adults past middle age, any age may be affected. Both sexes are equally affected, and rarely the disease may run in families. There is a higher incidence of myelofibrosis in children with Down’s syndrome.

Clinical features: The onset is insidious with vague ill health and development of abdominal mass. A majority of cases are mildly anemic with Hb 5-9 g/dl. The prominent feature is below the costal margin. Liver may be moderately enlarged up to 6-10 cm. Lymph node enlargement, mild jaundice and bleeding manifestations may be rarely present.

The classical blood picture is leukoerythroblastic anemia. Both immature erythroid and myeloid precursors are present in peripheral blood. The erythrocytes show marked aniso and poikilocytosis, polychromasia and “teardrop” appearance. There is moderate leucocytosis. Total leucocyte count may reach 20- 30,000/cmm. Platelet count is usually normal or increased and the morphology may be abnormal with many giant platelets. Megakaryocytic fragments may be seen in peripheral blood. In the late stages thrombocytopenia may occur. Platelet function may be defective.

Bone marrow aspiration usually gives a dry tap. Foci of extramedullary hematopoiesis can be demonstrated in the spleen, liver and rarely lymph nodes. Radiographs of bones show osteosclerosis with obliteration of marrow cavity. Changes are most markedly seen in the vertebrae, shafts of long bones of the extremities, ribs, clavicles and pelvis. Serum uric acid is increased. Leucocyte alkaline phosphatase is high.

Myelofibrosis Blood Film

Source

Gross Splenomegaly

Source

Diagnosis And Treatment

Diagnosis: Myelosclerosis should be suspected in any patient presenting with mild to moderate anemia, gross splenomegaly, leukoerythroblastic blood picture, and repeated dry taps of the bone marrow.

The condition has to be differentiated from chronic myeloid leukemia (CML). In CML, splenomegaly is directly proportional to the leukocyte count, leukocyte alkaline phosphatase activity is low. Philadelphia chromosome may be demonstrated.

Leucoerythroblastic blood picture may be encountered in acute hemolytic crisis, sudden hemorrhage, secondaries in the bone marrow and secondary myelofibrosis.

Course and prognosis: The disease follows a protracted course with the median survival period of 3-4 years. With judicious management, many cases live up to 10 years or more. When the spleen assumes a large size, hyper-splenism may develop.

Complications:These are hypersplenism, surgical complications of the spleen, development of acute myeloid leukemia, secondary gout and hemorrhages.

Treatment: There is no specific therapy, it is symptomatic. When there is evidence of hyperplasia of bone marrow and hypermetabolism, busulfan given in doses of 2-4 mg/day may be symptomatically beneficial. Splenectomy acts as a source of blood cells, but if hyper-splenism develops, splenectomy is indicated. Isotopic studies help in determining whether the spleen is more active in producing or destroying blood cells.

Secondary Myelofibrosis

This occurs as a terminal complication of polycythemia vera, chronic myeloid leukemia, disseminated tuberculosis involving the bone marrow, irradiation, toxicity to drugs like benzene and chloramphenicol, secondary carcinoma affecting the bone marrow, Paget’s disease of bone and Albers-Schonberg’s disease.

© 2014 Funom Theophilus Makama

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: "https://hubpages.com/privacy-policy#gdpr"

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)